Belite Bio, Inc ( BLTE) - Key Metrics
BLTE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0 | -$0.68 | $0 | $0 |
| 2025Q4 | $0 | -$0.76 | $0 | $0 |
| 2025Q3 | $0 | -$0.65 | $0 | $0 |
| 2025Q2 | $0 | -$0.50 | $0 | $0 |
| 2025Q1 | $0 | -$0.44 | $0 | $0 |
BLTE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -58.62 |
| 2025Q4 | 0% | -55.54 |
| 2025Q3 | 0% | -28.46 |
| 2025Q2 | 0% | -28.85 |
| 2025Q1 | 0% | -37.63 |
BLTE
Price: $168.55
52 week price:
Earnings Per Share: -2.68 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 6.6 billion